Market Overview:
The global avidin market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for avidin in research laboratories and hospitals. Additionally, the growing awareness about the benefits of avidin is also contributing to the growth of this market. On the basis of type, recombinant avidin accounted for a major share of the global avidin market in 2017. This segment is expected to grow at a CAGR of 5.8% from 2018 to 2030 owing to its high efficiency and specificity compared with native avidin.
Product Definition:
Avidin is a glycoprotein that is found in egg white. It binds to biotin and inhibits its absorption. Avidin is used as an assay reagent to determine the presence of biotin in a sample.
Recombinant Avidin:
Recombinant avidin, also known as biotin-binding protein is a protein that binds biotin. It is manufactured by the fermentation of Escherichia coli and can be purified by using conventional techniques such as gel filtration, ion exchange, and centrifugation. Recombinant Avidin has applications in diagnostic tests for cancer & cardiovascular diseases; it helps detect the presence of tumor-specific antigens in patients’ urine or blood samples.
Native Avidin:
Avidin is a naturally occurring biodegradable polymer, derived from the amino acid lysine. Avidin finds application in diagnostic and research laboratories as well as in the medical industry for therapeutic purposes. It is used to treat diseases such as rheumatoid arthritis by reducing inflammation. Avidin also has applications in ophthalmic surgery and dentistry for its use during surgeries to prevent infections from bleeding or swelling of tissues or cells respectively.
Application Insights:
The other application segment includes biopharmaceutical manufacturing, research laboratories and hospital. Avidin is used in the production of biopharmaceuticals including monoclonal antibodies (mAb), recombinant proteins and vaccines. The growing use of avidin in the production of drugs for cancer treatment, hepatitis A & B, HIV infection and autoimmune diseases drives its demand worldwide.
Avidin is widely used as an animal protein substitute in food products such as nutritional supplements to maintain ideal body weight among athletes, bodybuilders and patients undergoing dialysis due to low cost compared to animal-based products. This trend may increase product demand over the forecast period since it has a high bio-availability rate which makes it suitable for consumption by humans even without any additional ingredients or additives added into it like other dietary supplements on a global scale.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and pharmaceutical companies, which are major users as well as suppliers of avidin, is one of the primary reasons for its dominance. Moreover, increasing R&D activities on therapeutic proteins and peptides coupled with high healthcare spending in this region is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to rising investments by domestic and international players for commercializing products at a relatively lower price compared to their North American counterparts. In addition, growing healthcare expenditure levels coupled with improving economic conditions are likely to contribute toward higher product demand over this period.
Growth Factors:
- Increasing demand for biotechnology and life science research
- Growing application of avidin in diagnostics and therapeutics
- Rising number of research collaborations and initiatives for avidin development
- Proliferation of new technologies for avidin detection and characterization
- Increasing investments in the field of biotechnology
Scope Of The Report
Report Attributes
Report Details
Report Title
Avidin Market Research Report
By Type
Recombinant Avidin, Native Avidin
By Application
Research Laboratory, Hospital, Others
By Companies
AnaSpec, Inc., Avantor, Inc., BioVision，Inc., MEDICAL and BIOLOGICAL LABORATORIES CO., LTD., Merck., MP Biomedicals, Rockland Immunochemicals, Inc., SouthernBiotech, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Avidin Market Report Segments:
The global Avidin market is segmented on the basis of:
Types
Recombinant Avidin, Native Avidin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Laboratory, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AnaSpec, Inc.
- Avantor, Inc.
- BioVision，Inc.
- MEDICAL and BIOLOGICAL LABORATORIES CO., LTD.
- Merck.
- MP Biomedicals
- Rockland Immunochemicals, Inc.
- SouthernBiotech
- Thermo Fisher Scientific
Highlights of The Avidin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Recombinant Avidin
- Native Avidin
- By Application:
- Research Laboratory
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Avidin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Avidin is a protein that helps the body bind to and recognize other proteins. It is found in many foods, including eggs, milk, cheese, and meats.
Some of the key players operating in the avidin market are AnaSpec, Inc., Avantor, Inc., BioVision，Inc., MEDICAL and BIOLOGICAL LABORATORIES CO., LTD., Merck., MP Biomedicals, Rockland Immunochemicals, Inc., SouthernBiotech, Thermo Fisher Scientific.
The avidin market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Avidin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Avidin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Avidin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Avidin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Avidin Market Size & Forecast, 2020-2028
4.5.1 Avidin Market Size and Y-o-Y Growth
4.5.2 Avidin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Recombinant Avidin
5.2.2 Native Avidin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research Laboratory
6.2.2 Hospital
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Avidin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Avidin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Recombinant Avidin
9.6.2 Native Avidin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research Laboratory
9.10.2 Hospital
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Recombinant Avidin
10.6.2 Native Avidin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research Laboratory
10.10.2 Hospital
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Recombinant Avidin
11.6.2 Native Avidin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research Laboratory
11.10.2 Hospital
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Recombinant Avidin
12.6.2 Native Avidin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research Laboratory
12.10.2 Hospital
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Recombinant Avidin
13.6.2 Native Avidin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research Laboratory
13.10.2 Hospital
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Avidin Market: Competitive Dashboard
14.2 Global Avidin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AnaSpec, Inc.
14.3.2 Avantor, Inc.
14.3.3 BioVision，Inc.
14.3.4 MEDICAL and BIOLOGICAL LABORATORIES CO., LTD.
14.3.5 Merck.
14.3.6 MP Biomedicals
14.3.7 Rockland Immunochemicals, Inc.
14.3.8 SouthernBiotech
14.3.9 Thermo Fisher Scientific
